Stock Events

Stock Events

Novavax 

€7.33
1100
-€0.08-1.08% Thursday 19:55

Statistics

Day High
7.44
Day Low
7.21
52W High
9.45
52W Low
5.12
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Dec 7
€0.08
Nov 7
€0.08
Oct 7
€0.08
Sep 7
€0.08
Aug 7
€0.08
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MayExpected
Q4 2025
Next
-0.41
-0.24
-0.07
0.09
Expected EPS
-0.19452373269
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVV1.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap21.3B
Moderna is a direct competitor in the mRNA vaccine space, particularly for COVID-19, similar to Novavax's efforts in vaccine development.
Pfizer
PFE
Mkt Cap156.77B
Pfizer, in collaboration with BioNTech, developed a COVID-19 vaccine that competes directly with Novavax's COVID-19 vaccine.
BioNTech
BNTX
Mkt Cap26.03B
BioNTech partners with Pfizer for the COVID-19 vaccine, making it a direct competitor to Novavax in the vaccine market.
Johnson & Johnson
JNJ
Mkt Cap564.35B
Johnson & Johnson developed a single-shot COVID-19 vaccine, competing in the same pandemic response market as Novavax.
Astrazeneca
AZN
Mkt Cap317.5B
AstraZeneca developed a COVID-19 vaccine using a different technology but competes in the same global vaccine market as Novavax.
Sanofi
SNY
Mkt Cap115.14B
Sanofi is working on COVID-19 vaccine candidates and influenza vaccines, positioning it as a competitor in the broader vaccine market.
GSK
GSK
Mkt Cap117.55B
GlaxoSmithKline, with its extensive vaccine portfolio and efforts in COVID-19 vaccine development, competes in the same space as Novavax.
Novavax
NVAX
Mkt Cap1.44B
Dynavax offers adjuvants for vaccines, making it a competitor in the broader vaccine development and enhancement market.

About

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Show more...
CEO
Mr. John Charles Jacobs M.B.A.
Employees
749
Country
United States
ISIN
US6700024010

Listings

VI
AT
NVAX.VI
STU
DE
NVV1.STU
MU
DE
NVV1.MU
LSE
GB
0A3S.LSE

0 Comments

Share your thoughts

FAQ

What is Novavax stock price today?▼
The current price of NVV1.STU is €7.33 EUR — it has decreased by -1.08% in the past 24 hours. Watch Novavax stock price performance more closely on the chart.
What is Novavax stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Novavax stocks are traded under the ticker NVV1.STU.
Is Novavax stock price growing?▼
NVV1.STU stock has risen by +6.08% compared to the previous week, the month change is a -12.08% fall, over the last year Novavax has showed a +39.81% increase.
When is the next Novavax earnings date?▼
Novavax is going to release the next earnings report on May 13, 2026.
What were Novavax earnings last quarter?▼
NVV1.STU earnings for the last quarter are 0.09 EUR per share, whereas the estimation was -0.41 EUR resulting in a +122.69% surprise. The estimated earnings for the next quarter are N/A EUR per share.
Does Novavax pay dividends?▼
Yes, NVV1.STU dividends are paid monthly. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Novavax have?▼
As of April 20, 2026, the company has 749 employees.
In which sector is Novavax located?▼
Novavax operates in the Manufacturing sector.
When did Novavax complete a stock split?▼
Novavax has not had any recent stock splits.
Where is Novavax headquartered?▼
Novavax is headquartered in Gaithersburg, United States.